|Articles|May 2, 2004
- Pharmaceutical Technology-05-02-2004
- Volume 28
- Issue 5
FDA Eyes Manufacturing Innovation to Boost Drug Development
Author(s)Jill Wechsler
New technologies, along with changes in FDA oversight, may provide a critical path to make more new drugs available more quickly to patients.
Advertisement
Articles in this issue
over 21 years ago
In The Spotlight-May 2004over 21 years ago
Prepare for Bar Codingover 21 years ago
aaiPharma Situation Underscores The Need for Due Diligenceover 21 years ago
Excipient Functionalityover 21 years ago
May 2004Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Sustainability and Stability in Excipients
2
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
5
